Effects of antiarrhythmic drug responsiveness and diagnosis-to-ablation time on outcomes after catheter ablation for persistent atrial fibrillation.
Hong-Ju KimDaehoon KimKipoong KimSung Hwa ChoiMoon-Hyun KimJe-Wook ParkHee Tae YuTae-Hoon KimJae Sun UhmBoyoung JoungMoon-Hyoung LeeHui Nam PakPublished in: Journal of arrhythmia (2024)
Both DAT and AAD responsiveness influenced AFCA rhythm outcomes. Delaying AFCA to a DAT of longer than 22 months was inadvisable, particularly in the participants in whom PeAF was changed to paroxysmal AF during AAD therapy.
Keyphrases
- catheter ablation
- atrial fibrillation
- left atrial
- left atrial appendage
- oral anticoagulants
- direct oral anticoagulants
- heart failure
- percutaneous coronary intervention
- stem cells
- type diabetes
- emergency department
- metabolic syndrome
- adverse drug
- adipose tissue
- coronary artery disease
- blood pressure
- mesenchymal stem cells
- venous thromboembolism
- weight loss
- glycemic control
- replacement therapy
- electronic health record
- cell therapy
- heart rate
- radiofrequency ablation